Financials
- Market Capitalization 1.95 B
- Employee 260
- Founded 1997
- CEO N/A
- Website www.xencor.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG4W0
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-12.35
Rapporto prezzo/fatturato
9.05
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2006 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.58 USD | -2.04% | +1.63% | -6.28% | -22.61% | 2.00 B USD | ||
| 2017 | NBTX Nanobiotix S.A. - ADSs | 41.08 USD | -9.03% | -5.67% | +9.49% | +341.72% | 1.99 B USD | ||
| 2051 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.78 USD | -3.02% | -5.09% | +6.84% | +103.52% | 1.88 B USD | ||
| 2052 | IMCR Immunocore Holdings plc - American Depositary Shares | 36.38 USD | -1.01% | -1.14% | +8.89% | +8.66% | 1.87 B USD |